₩6,550.00 ($4.88)

-30.00 (-0.46%)

Weekly Expected Move ±4.4%

₩5976 ₩6263 ₩6550 ₩6837 ₩7124

KSC · Healthcare · Medical - Pharmaceuticals · Tech Score Buy · Power 58 · ₩325.3B mcap · 27M float · 0.664% daily turnover

Revenue

$1.66T +1.1% ▲

5Y CAGR: +5.9%

Gross Profit

$293.2B -2.0% ▼

5Y CAGR: +2.6%

Operating Income

$31.0B +3.2% ▲

5Y CAGR: -7.8%

Net Income

$21.0B -48.2% ▼

5Y CAGR: -14.3%

EPS (Diluted)

$448.05 -55.6% ▼

5Y CAGR: -16.7%

EBITDA

$48.5B +8.8% ▲

5Y CAGR: -10.6%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$1.34T	$1.43T	$1.51T	$1.64T	$1.66T
YoY Growth	+7.6%	+7.0%	+5.8%	+8.3%	+1.1%
Cost of Revenue	$1.06T	$1.15T	$1.22T	$1.34T	$1.37T
Gross Profit	$274.3B	$282.0B	$295.1B	$299.3B	$293.2B
Gross Margin	20.5%	19.7%	19.5%	18.2%	17.7%
R&D Expenses	$8.3B	$9.7B	$15.3B	$10.1B	$0
SG&A Expenses	$137.2B	$140.9B	$233.8B	$154.3B	$0
Operating Expenses	$229.3B	$243.8B	$249.1B	$269.2B	$262.2B
Operating Income	$44.9B	$38.2B	$48.8B	$30.1B	$31.0B
Operating Margin	3.4%	2.7%	3.2%	1.8%	1.9%
Interest Expense	$2.5B	$3.7B	$6.9B	$10.3B	$11.0B
Income Before Tax	$34.3B	$36.3B	$49.0B	$57.3B	$31.0B
Tax Expense	$8.8B	$9.6B	$9.6B	$15.5B	$9.7B
Net Income	$24.0B	$24.2B	$37.0B	$40.5B	$21.0B
Net Margin	1.8%	1.7%	2.4%	2.5%	1.3%
EPS (Diluted)	$584.33	$588.45	$913.39	$1010.12	$448.05
EBITDA	$51.0B	$54.0B	$55.0B	$44.6B	$48.5B
Shares Outstanding	41M	41M	40M	40M	52M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$424.6B	$390.8B	$377.6B	$425.3B	$444.5B	$412.1B	$410.9B	$439.8B
Cost of Revenue	$352.8B	$318.2B	$310.8B	$352.8B	$363.8B	$338.9B	$338.5B	$365.3B
Gross Profit	$71.8B	$72.6B	$66.8B	$72.5B	$80.7B	$73.2B	$72.3B	$74.5B
Gross Margin	16.9%	18.6%	17.7%	17.0%	18.1%	17.8%	17.6%	16.9%
R&D Expenses	$2.4B	$2.6B	$0	$1.8B	$2.3B	$2.5B	$3.0B	$0
SG&A Expenses	$41.8B	$34.3B	$35.5B	$67.9B	$40.0B	$36.2B	$35.3B	$42.8B
Operating Expenses	$70.4B	$65.9B	$63.5B	$67.9B	$69.8B	$60.9B	$64.8B	$71.7B
Operating Income	$1.4B	$6.7B	$3.3B	$4.5B	$10.9B	$12.3B	$7.5B	$2.8B
Operating Margin	0.3%	1.7%	0.9%	1.1%	2.4%	3.0%	1.8%	0.6%
Interest Expense	$2.4B	$2.8B	$2.8B	$2.9B	$2.6B	$2.7B	$3.0B	$3.1B
Income Before Tax	$12.0B	$17.2B	$5.2B	$3.9B	$14.3B	$7.6B	$6.6B	$4.4B
Tax Expense	$3.0B	$4.3B	$1.2B	$1.5B	$3.2B	$3.8B	$1.7B	$1.3B
Net Income	$8.8B	$12.1B	$3.7B	$2.5B	$10.8B	$3.9B	$4.4B	$2.7B
Net Margin	2.1%	3.1%	1.0%	0.6%	2.4%	1.0%	1.1%	0.6%
EPS (Diluted)	$220.00	$302.96	$95.42	$64.00	$275.00	$87.27	$88.23	$54.00
EBITDA	$17.8B	$10.5B	$7.5B	$77.1B	$21.6B	-$57.6B	$13.0B	$8.3B
Shares Outstanding	40M	40M	39M	39M	39M	48M	50M	58M

009290.KS KSC